Blurbs

Tenet Healthcare (THC) Gets a Buy Rating from RBC Capital

RBC Capital analyst Ben Hendrix maintained a Buy rating on Tenet Healthcare (THCResearch Report) on July 7 and set a price target of $104.00. The company’s shares closed last Friday at $55.14, close to its 52-week low of $50.37.

According to TipRanks.com, Hendrix is a 1-star analyst with an average return of -8.4% and a 43.2% success rate. Hendrix covers the Healthcare sector, focusing on stocks such as Aveanna Healthcare Holdings, Brookdale Senior Living, and Bright Health Group.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Tenet Healthcare with a $95.80 average price target, a 73.3% upside from current levels. In a report issued on July 1, Mizuho Securities also maintained a Buy rating on the stock with a $63.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

Tenet Healthcare’s market cap is currently $5.95B and has a P/E ratio of 6.30.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Tenet Healthcare Corp. engages in the provision of health care services. Through its subsidiaries and affiliates, it owns and facilitates acute care hospitals, ambulatory surgery centers, diagnostic imaging centers, and related health care facilities. It operates through the following business segments: Hospital Operations and Other, Ambulatory Care, and Conifer. The Hospital Operations and Other segment comprises of acute care hospitals, ancillary outpatient facilities, urgent care centers, microhospitals and physician practices. The Ambulatory Care segment includes operations of USPI joint venture and the company’s nine Aspen facilities in the United Kingdom. The Conifer segment offers healthcare business process services in the areas of hospital and physician revenue cycle management and value-based care solutions to healthcare systems, as well as individual hospitals, physician practices, self-insured organizations, health plans, and other entities. The company was founded in 1975 and is headquartered in Dallas, TX.

Read More on THC:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More
Videos